Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

Please read the full announcement in PDF Attachment 2023_Conditional_competition_clearance_from_the_EC
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Please read the full announcement in PDF

Attachment

  • 2023_Conditional_competition_clearance_from_the_EC

Per maggiori informazioni
Sito Web
novozymes.com

Ufficio Stampa

 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti

Allegati
Slide ShowSlide Show
Non disponibili
;